TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
30,255,960
Share change
+354,724
Total reported value
$190,611,820
Put/Call ratio
111%
Price per share
$6.30
Number of holders
99
Value change
+$1,184,065
Number of buys
47
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q4 2017

As of 31 Dec 2017, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,255,960 shares. The largest 10 holders included BlackRock Inc., MILLENNIUM MANAGEMENT LLC, CANADA PENSION PLAN INVESTMENT BOARD, Vanguard Group Inc, Numeric Investors LLC, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, FMR LLC, and STATE STREET CORP. This page lists 99 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.